For research use only. Not for therapeutic Use.
Rohinitib（Cat No.:I042480）is a small molecule compound under investigation for its potential therapeutic applications in cancer treatment. It functions as a selective inhibitor of specific kinases involved in cell signaling pathways that regulate cell growth, survival, and metastasis. By targeting these kinases, Rohinitib aims to disrupt the signaling pathways that promote tumor growth, making it a promising candidate for treating various cancers, including those with resistance to traditional therapies. Ongoing research is focused on evaluating its efficacy, safety, and potential as a targeted treatment option for different malignancies.
| CAS Number | 1139253-73-8 |
| Synonyms | (1R,2R,3S,3aR,8bS)-1,8b-dihydroxy-N,6,8-trimethoxy-3a-(4-methoxyphenyl)-N-methyl-3-phenyl-2,3-dihydro-1H-cyclopenta[b][1]benzofuran-2-carboxamide |
| Molecular Formula | C29H31NO8 |
| Purity | ≥95% |
| IUPAC Name | (1R,2R,3S,3aR,8bS)-1,8b-dihydroxy-N,6,8-trimethoxy-3a-(4-methoxyphenyl)-N-methyl-3-phenyl-2,3-dihydro-1H-cyclopenta[b][1]benzofuran-2-carboxamide |
| InChI | InChI=1S/C29H31NO8/c1-30(37-5)27(32)23-24(17-9-7-6-8-10-17)29(18-11-13-19(34-2)14-12-18)28(33,26(23)31)25-21(36-4)15-20(35-3)16-22(25)38-29/h6-16,23-24,26,31,33H,1-5H3/t23-,24-,26-,28+,29+/m1/s1 |
| InChIKey | TZDAVNWDKGYBCW-IDAMAFBJSA-N |
| SMILES | CN(C(=O)[C@@H]1[C@H]([C@]2([C@@]([C@@H]1O)(C3=C(O2)C=C(C=C3OC)OC)O)C4=CC=C(C=C4)OC)C5=CC=CC=C5)OC |
